Vanguard Global Advisers »

Amylyx Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $665k 48k 13.90

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Vanguard Group
Commodore Capital
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
First Light Asset Management
Driehaus Capital Management
Adage Capital Partners GP
Goldman Sachs Group
Franklin Resources
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals